| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 287 | 2018 |
| Review of opioid pharmacogenetics and considerations for pain management A Owusu Obeng, I Hamadeh, M Smith Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (9 …, 2017 | 188 | 2017 |
| Drug induced osteonecrosis of the jaw IS Hamadeh, BA Ngwa, Y Gong Cancer treatment reviews 41 (5), 455-464, 2015 | 140 | 2015 |
| Osteonecrosis of the jaw in the United States Food and Drug Administration's adverse event reporting system (FAERS) X Zhang, IS Hamadeh, S Song, J Katz, JS Moreb, TY Langaee, LJ Lesko, ... Journal of Bone and Mineral Research 31 (2), 336-340, 2016 | 116 | 2016 |
| Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate IS Hamadeh, TY Langaee, R Dwivedi, S Garcia, BM Burkley, TC Skaar, ... Clinical Pharmacology & Therapeutics 96 (2), 175-181, 2014 | 110 | 2014 |
| Optimization of voriconazole therapy for the treatment of invasive fungal infections in adults N Mangal, IS Hamadeh, MJ Arwood, LH Cavallari, TS Samant, KP Klinker, ... Clinical Pharmacology & Therapeutics 104 (5), 957-965, 2018 | 57 | 2018 |
| Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections IS Hamadeh, KP Klinker, SJ Borgert, AI Richards, W Li, N Mangal, ... Pharmacogenetics and genomics 27 (5), 190-196, 2017 | 56 | 2017 |
| Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy AR Mato, N Ghosh, SJ Schuster, N Lamanna, JM Pagel, IW Flinn, ... Blood, The Journal of the American Society of Hematology 137 (20), 2817-2826, 2021 | 48 | 2021 |
| A novel simple method for determining CYP2D6 gene copy number and identifying allele (s) with duplication/multiplication T Langaee, I Hamadeh, AB Chapman, JG Gums, JA Johnson PLoS One 10 (1), e0113808, 2015 | 46 | 2015 |
| Personalizing aromatase inhibitor therapy in patients with breast cancer IS Hamadeh, JN Patel, S Rusin, AR Tan Cancer treatment reviews 70, 47-55, 2018 | 45 | 2018 |
| SIRT1/HERC4 Locus Associated With Bisphosphonate‐Induced Osteonecrosis of the Jaw: An Exome‐Wide Association Analysis G Yang, IS Hamadeh, J Katz, A Riva, P Lakatos, B Balla, J Kosa, ... Journal of Bone and Mineral Research 33 (1), 91-98, 2018 | 43 | 2018 |
| Pharmacogenomics of osteonecrosis of the jaw G Yang, S Singh, Y Chen, IS Hamadeh, T Langaee, CW McDonough, ... Bone 124, 75-82, 2019 | 41 | 2019 |
| Evaluation of CYP 2C19 Genotype‐Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant JN Patel, IS Hamadeh, M Robinson, Z Shahid, J Symanowski, ... Clinical Pharmacology & Therapeutics 107 (3), 571-579, 2020 | 33 | 2020 |
| Effect of CYP3A4, CYP3A5, and ABCB1 polymorphisms on intravenous tacrolimus exposure and adverse events in adult allogeneic stem cell transplant patients IS Hamadeh, Q Zhang, N Steuerwald, A Hamilton, LJ Druhan, M McSwain, ... Biology of Blood and Marrow Transplantation 25 (4), 656-663, 2019 | 29 | 2019 |
| Loss of Heterozygosity at the CYP2D6 Locus in Breast Cancer: Implications for Tamoxifen Pharmacogenetic Studies JA Johnson, IS Hamadeh, TY Langaee Journal of the National Cancer Institute 107 (2), dju437, 2015 | 25 | 2015 |
| CD8 effector T cells enhance teclistamab response in BCMA-exposed and-naïve multiple myeloma RS Firestone, D McAvoy, T Shekarkhand, E Serrano, I Hamadeh, A Wang, ... Blood advances 8 (7), 1600-1611, 2024 | 23 | 2024 |
| The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression TY Langaee, G Zhong, W Li, I Hamadeh, MHM Solayman, ... Pharmacogenetics and genomics 25 (5), 239-245, 2015 | 22 | 2015 |
| Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype‐Derived Activity Scores CD Thomas, SA Mosley, S Kim, K Lingineni, N El Rouby, TY Langaee, ... CPT: Pharmacometrics & Systems Pharmacology 9 (12), 678-685, 2020 | 21 | 2020 |
| Safety and cost benefits of the rapid daratumumab infusion protocol IS Hamadeh, ES Reese, JR Arnall, E Kachur, AL Martin, M Schneider, ... Clinical Lymphoma Myeloma and Leukemia 20 (8), 526-532. e1, 2020 | 17 | 2020 |
| Pain management using clinical pharmacy assessments with and without pharmacogenomics in an oncology palliative medicine clinic JN Patel, D Boselli, IS Hamadeh, J Symanowski, R Edwards, B Susi, ... Journal of Oncology Practice 16 (2), e166-e174, 2020 | 15 | 2020 |
